SUMMARY
Dendritic cells (DCs), monocytes, and macrophages are leukocytes with critical roles in immunity and tolerance. The DC network is evolutionarily conserved; the homologs of human tissue CD141 hi XCR1 + CLEC9A + DCs and CD1c + DCs are murine CD103 + DCs and CD64 À CD11b + DCs. In addition, human tissues also contain CD14 + cells, currently designated as DCs, with an as-yet unknown murine counterpart. Here we have demonstrated that human dermal CD14
+ cells are a tissue-resident population of monocyte-derived macrophages with a short half-life of <6 days. The decline and reconstitution kinetics of human blood CD14 + monocytes and dermal CD14 + cells in vivo supported their precursor-progeny relationship. The murine homologs of human dermal CD14 + cells are CD11b + CD64 + monocytederived macrophages. Human and mouse monocytes and macrophages were defined by highly conserved gene transcripts, which were distinct from DCs. The demonstration of monocyte-derived macrophages in the steady state in human tissue supports a conserved organization of human and mouse mononuclear phagocyte system.
INTRODUCTION
Dendritic cells (DCs) and macrophages are a heterogeneous population of leukocytes that are critical in orchestrating immune responses (Steinman, 2007) . Human tissues are populated by at least three DC subsets; CD141 hi DCs (Haniffa et al., 2012; Watchmaker et al., 2014) , CD1c + DCs (Lenz et al., 1993; Morelli et al., 2005; Angel et al., 2006; Zaba et al., 2007) , and CD14 + DCs (Nestle et al., 1993; de Gruijl et al., 2006; Klechevsky et al., 2008; Haniffa et al., 2009) . Gene-expression studies suggest that human blood and tissue CD141 hi DCs are homologous to murine tissue CD103 + and splenic CD8 + DCs (Robbins et al., 2008; Bachem et al., 2010; Crozat et al., 2010; Jongbloed et al., 2010; Poulin et al., 2010) and CD1c + DCs are homologous to CD11b + CD4 + DCs in the spleen and CD11b + CD24 + CD64
À DCs in nonlymphoid tissues . However, the precise relationship of human CD14 + DCs to murine tissue populations remains unclear (Haniffa et al., 2012) . Excluding Langerhans cells of the epidermis, the apparent paradox of three DC subsets in human interstitial tissues but only two in murine tissues remains unreconciled. Human CD14 + DCs were first identified as a spontaneously migrating population from dermal explants cultured ex vivo. These cells were classified as DCs based on major histocompatibility complex (MHC) class II glycoprotein expression and their ex vivo migratory behavior. In vitro generated CD14 + DCs from CD34 + hematopoietic stem cells (HSCs) have been used alongside primary cells to dissect their immunological properties (Caux et al., 1996; Klechevsky et al., 2008; Morelli et al., 2005; de Gruijl et al., 2006; Angel et al., 2006; Haniffa et al., 2009; Haniffa et al., 2012; Matthews et al., 2012; Penel-Sotirakis et al., 2012) . CD14 + DCs secrete interleukin-10 (IL-10) and IL-6 and have been shown to induce regulatory T cells (Tregs) and helper follicular T cells (Tfh) (Chu et al., 2012; Klechevsky et al., 2008) . A notable feature of CD14 + DCs is their poor ability to stimulate allogeneic T cell proliferation (Klechevsky et al., 2008; Morelli et al., 2005; de Gruijl et al., 2006) . CD14 + DCs also express CD141, which is further upregulated during spontaneous migration from skin explant culture and initially presumed to be related to blood CD141 + DCs (Chu et al., 2012) . More recently, the true counterpart of blood CD141 + DCs has been shown to be tissue CD14 À CD141 hi DCs (Haniffa et al., 2012) . CD14 + cells are related to human and mouse blood monocytes by gene expression and are rapidly reconstituted by donorderived cells following hematopoietic stem cell transplantation (HSCT), unlike dermal macrophages, which turn over at a much slower rate (Haniffa et al., 2009; Haniffa et al., 2012) .
In mice, steady-state DCs are derived from a lineage dependent on FLT3, in contrast to monocytes and macrophages, which are dependent on colony-stimulating factor-1 receptor (CSF-1R) (Yoshida et al., 1990; McKenna et al., 2000; Dai et al., 2002 
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Human Dermal Monocyte-Derived Macrophages (Jakubzick et al., 2013; Tamoutounour et al., 2012) and also differentiate into DC-like and macrophage populations in the intestine and dermis (Bogunovic et al., 2009; Varol et al., 2009; Tamoutounour et al., 2012; Yona et al., 2013) . Monocytes as a source of tissue inflammatory DCs are also well-documented (Zigmond et al., 2012; Plantinga et al., 2013; Tamoutounour et al., 2013) . Human blood monocyte differentiation into DCs has been proposed in inflammation as the potential equivalent of in vitro cultured GM-CSF and IL-4 monocyte-derived DCs (Segura et al., 2013 
RESULTS

Tissue CD14
+ Cells Are Phenotypically Related to Blood
Monocytes and Interstitial Macrophages
We previously showed that CD14 + cells were distinct from dermal macrophages, which possessed dense cytoplasmic melanin granules by morphology, were autofluorescent by flow cytometry analysis, were adherent and nonmigratory, although both populations express CD14 (Haniffa et al., 2009 Figure 1A ). Both skin CD14 + cells and CFSE-labeled CD14 + monocytes spiked into the skin preparation had variable expression of CD141 ( Figure 1A ). We noted very few CD14 + cells with an identical profile to the CFSE-labeled monocytes cultured with digesting skin (Figure 1A) , which might represent extravasated tissue monocytes in healthy human skin.
We next compared the expression of selected antigens characterizing monocyte-macrophage cells in human skin and blood-antigen-presenting cell populations ( Figure 1B ). Unlike CD1c + DCs from blood and skin, CD14 + cells had variable expression of CD163 similar to blood monocytes and macrophages ( Figure 1B) . We next compared the expression of skin antigenpresenting cell subsets and blood CD14 + monocytes for the following transcripts; DC transcription factor (TF) ZBTB46, CD209, lymphatic vessel endothelial hyaluronan receptor (LYVE1), and factor XIIIa (F13A1). The latter three antigens were shown to identify dermal macrophages in situ (Wang et al., 2014) (Figure 1C (Segura et al., 2013; Tamoutounour et al., 2013) . CD14 + cells and macrophages expressed higher amounts of CD209 transcript compared to all other subsets, but LYVE1 transcript expression was highest in macrophages ( Figure 1C ) similar to F13A1 expression (Haniffa et al., 2009 ). In addition, dermal CD14 + cells expressed high amounts of IL1A and gamma-glutamyl transferase 5 (GGT5) transcripts ( Figure 1C ), which were identified from our previous microarray analysis (Haniffa et al., 2012 Figure 1D ).
Skin CD14 + Cells Are Derived from CD14 + Blood Monocytes Human tissue DCs are depleted in patients lacking circulating DCs and monocytes as shown by patients with genetic deficiency of monocytes and DCs due to GATA2 or IRF8 mutation, but the exact precursor-progeny relationships are difficult to demonstrate conclusively in humans Hambleton et al., 2011) . We previously showed that skin CD14 + cells are derived from donor bone marrow within 40 days of HSCT (Haniffa et al., 2009 ), but the kinetics of this relationship have not been resolved in detail. In this study, we followed the course of blood and skin monocytes, macrophages, and DCs during preparative cytotoxic therapy for transplantation and for up to 2 weeks after HSCT (clinical data in Table S1 ).
enzymatically digested skin (red) and phenotypically compared to CD14 + cells (blue Cytotoxic therapy induced bone-marrow suppression and absolute monocytopenia by the day of transplantation (day 0) (Figure 2A ). This was mirrored by a rapid loss of CD14 + cells from the skin within 6 days. After a delay of 6 days, macrophage numbers also declined to approximately 50%, where they remained stable. In the early recovery phase after HSCT, there was a rapid rise in CD14 + blood monocytes, which coincided with a rapid reconstitution of skin CD14 + cells ( Figure 2B ). The kinetics of DC recovery were slower in the blood and skin and did not attain the same frequency as healthy controls (Figures 2A and 2B Figure 2C ).
Skin CD14 + Cells Are Transcriptionally Aligned to Human Monocytes and Macrophages
In order to evaluate the lineage identity of human skin CD14 + cells, we performed microarray transcription profiling of human skin and blood dendritic cells, macrophages, and monocyte subsets. Principal component analysis (PCA) of all subsets analyzed showed separation of DCs from monocyte-macrophages in component one and further definition between monocyte-macrophage subsets and plasmacytoid DCs (pDCs) from myeloid DCs in component 2 ( Figure 3A) . We also performed a supervised connectivity map (CMAP) gene set enrichment analysis and showed that the CD14 + cell gene set was enriched in dermal macrophages and also weakly in CD14 + blood monocytes but exhibited an inverse expression profile to blood and skin DCs ( Figure 3B ). This suggests that CD14 + cells are more closely aligned to tissue macrophages and CD14 + blood monocytes than to blood or tissue DCs. Further examination of the relationship between CD14 + cells, monocytes, macrophages, and DCs revealed a number of coregulated genes distinguishing monocytes, CD14 + cells, and macrophages from blood and skin DCs ( Figure 3C ). Functional pathways identified by the monocyte, CD14 + cell, and macrophage gene sets include retinoid X receptor signaling, TREM1 signaling, complement system, and communication between innate and adaptive cell regulation (see Figure S1 available online). In contrast, the human DC gene signature was enriched for cell-cycle control and amino acid, nucleic acid and cholesterol metabolism pathways ( Figure S1 ).
We next performed cross-species analysis comparing human monocyte, macrophage, and CD14 + cells with murine monocytes, macrophages, and DC subsets obtained from ImmGen and GSE49358 (Tamoutounour et al., 2013) microarray data sets. This analysis identified a set of genes that are differentially expressed in a conserved manner, which include SLC11A1, MAFB, CD14, and FCGR2A ( Figure 3D ; Table  S2 ). Similarly, human and mouse DC lineage also shared close homology of transcripts across species including FLT3, BTLA, HLA-DOA, and CIITA ( Figure 3D ; Table S2 ).
Spontaneous Migration of Skin CD14 + Cells Does Not Occur via Lymphatic Vessels A defining property of tissue-resident DCs is their migratory capacity to lymph node (LN) directed by CCL19 and CCL21 signaling through CCR7. In vitro culture of explanted tissue mimics this process and resident DCs might be observed entering the lymphatic channels prior to emigrating from the tissue (Stoitzner et al., 1999; Ohl et al., 2004; Wang et al., 2014) . In addition, this experiment showed that resident macrophages remain fixed in the tissue (Haniffa et al., 2009; Wang et al., 2014) . The ability of CD14 + cells to leave tissue explants has been invoked as a DC credential (Nestle et al., 1993) , but their route of migration in the ex vivo assay has not yet been established. If CD14 + cells are not fixed in skin explants, then simple redistribution in ex vivo culture would result in apparent emigration from the tissue. Like dermal macrophages, migrated and digested CD14 + cells did not express CCR7 even upon stimulation ( Figure 4A ) (Haniffa et al., 2009) . Time-course analysis of skin explants showed the presence of CD14 + cells in the skin explant medium as early as 12 hr after culture ( Figure 4B ). However, at no stage were CD14 + cells observed within lymphatics as assessed by whole-mount immunostaining of skin explants (Figure 4C) . DC-SIGN expression is retained by spontaneously migrating CD14 + cells ( Figure S2 ) and would have permitted their localization within lymphatic channels if this had been the route of migration. The presence of spontaneously migrated CD14 + cells, despite their absence within skin lymphatic lumen, suggests that CD14 + cells exited from the skin without entering the lymphatic vasculature. Dermal macrophages did not migrate spontaneously ( Figure 4C ), in keeping with previous observations (Haniffa et al., 2009 (Klechevsky et al., 2008; Angel et al., 2006) , but a direct comparison with dermal macrophages has never been performed. 
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Human Dermal Monocyte-Derived Macrophages even at the highest APC: T cell ratio tested of 1:10 ( Figure 5A ). However, CD1c + DCs, CD14 + cells, and dermal macrophages were potent inducers of memory CD4 + T cell proliferation and cytokine production upon stimulation with Candida albicans (Figure 5B ). Both CD14 + cells and dermal macrophages were comparable to CD1c in their ability to induce IL-17, IL-22, interferon-g (IFN-g), and IL-4 production by memory CD4 + T cells ( Figure 5B ). (Langlet et al., 2012; Tamoutounour et al., 2012) . In order to precisely identify the murine equivalent of human CD14 + cells, we performed comparative transcriptomics analysis by using microarray data of the recently described CD11b + monocyte, DC, and macrophage populations in murine dermis (Tamoutounour et al., 2013) . CMAP analysis revealed highest enrichment of human CD1c + DCs to their murine CD11b + DC counterpart in both steady state and upon inflammation induced by the contact hypersensitivity allergen DNFB ( Figure 6A ). The reciprocal relationship was also observed that human dermal macrophages had low but positive CMAP enrichment scores with murine macrophages and monocyte-derived cells ( Figure 6A ). Blood CD14 + monocytes had the highest enrichment score with mouse Ly6C hi blood monocytes in the steady state ( Figure 6A ), in keeping with previous analysis (Haniffa et al., 2012) . Human CD14 + cells were most enriched with murine macrophages (P4 and P5) followed by Ly6C lo MHC class II + monocyte-derived DC-like cells (P2 and P3) ( Figure 6A ). These results suggest that human CD14 + cells are related to monocytes but are not the equivalent of murine tissue monocytes (P1). The existence of murine monocyte-derived dermal macrophages was recently reported by Tamatounour et al. as observed by a reduction in P4 and P5 dermal macrophages in Ccr2 À/À mice. We therefore hypothesized that human CD14 + cells were the homolog of murine dermal monocyte-derived macrophages. In order to confirm the monocyte origin of some murine dermal macrophages, we used the S100a4-cre 3 R26 YFP mice in which >99% of hematopoietic stem cells (HSCs) and resultant blood monocytes express yellow fluorescent protein (YFP). This fate-mapping model previously demonstrated the independence of resident tissue macrophages from circulating monocytes and HSC progenitors (Hashimoto et al., 2013) . Our analysis of mouse dermal DC and macrophage fractions showed that >90% of CD11b + P1-P3
Murine
and 80%-90% of P4 and P5 macrophages were indeed monocyte-derived ( Figure 6B ). Collectively, these results provide further evidence of functional equivalence between monocytederived macrophages in the mouse dermis as the homologs of human CD14 + cells.
DISCUSSION
The results presented here suggest that CD14 + ''DCs'' are not related to the human DC lineage but are monocyte-derived macrophages that are resident in healthy skin. Their gene-expression program strongly overlaps with that of blood monocytes and resident tissue macrophages, but they are distinguishable from both of these by phenotypic and functional properties. Although it is difficult to prove unequivocally that they have a monocyte origin, their absence in monocyte deficiency states, kinetics of renewal after HSCT, and similarity to monocytes in short-term culture with endothelial cells are all consistent with a precursor-progeny relationship. Their evident lack of ability to stimulate naive T cell proliferation is consistent with their status as a monocyte-derived macrophage. Tissue monocytes coexpressing Ly6C and MHC class II were recently demonstrated as a distinct population in murine tissues (Jakubzick et al., 2013; Tamoutounour et al., 2013 (Autissier et al., 2010) . ''Spiking'' CFSE-labeled blood CD14 + monocytes into digesting skin allowed us to perform a direct comparison between dermal CD14 + and blood monocytes. The identity of the circulating precursors of human tissue DCs and macrophages has been a subject of intense debate. Despite the widespread use of in vitro culture protocols to generate monocyte-derived DCs and macrophages, in vivo evidence to support the contribution of such monocyte-derived cells in healthy tissue is limited (Chu et al., 2012) . Here, we show the rapid decline and reconstitution of dermal CD14 + cells that mirrors the kinetics of blood CD14 + monocytes in patients undergoing HSCT. In contrast, blood and skin CD1c + DCs remained suppressed up to 14 days after HSCT and are thus unlikely to be the precursors of dermal CD14 + cells. We also show that blood CD14 + monocytes acquire the morphology and phenotypic characteristics of dermal CD14 + cells upon culture with endothelial cells in line with previous reports (Randolph et al., 1998; Chomarat et al., 2000) . The reduction of dermal macrophages after HSCT by approximately 50% is in keeping with the reduction in dermal macrophages in patients with GATA2 and IRF8 mutation who are deficient in peripheral blood DCs 
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Human Dermal Monocyte-Derived Macrophages and monocytes Hambleton et al., 2011) . Longer-term follow up after HSCT is required to evaluate macrophage recovery and whether proliferation of residual dermal macrophages or differentiation from CD14 + cells is responsible for dermal macrophage reconstitution.
The utility of transcriptomics analysis to map homologous subsets between humans and mice (Robbins et al., 2008; Haniffa et al., 2012; Schlitzer et al., 2013; Watchmaker et al., 2014) and more recently to define DCs and macrophages in mouse tissues is evident. Extending our previous CMAP analysis to human microarray data set incorporating dermal macrophages and epidermal LCs, we were able to precisely identify the monocyte-macrophage lineage of dermal CD14 + cells. This identification enabled us to define the human DC and monocyte-macrophage transcriptomic signatures and to perform cross-species analysis with the murine DC, monocyte, and macrophage ImmGen data set. The extension of human DC, monocyte, and macrophage mapping further enhances the utility of the ImmGen data repository. Our analysis confirms a high-degree of conservation for DC and macrophage transcription networks between humans and mice identifying shared genes such as MERTK, CD14, and SLC11A1 (NRAMP) to define monocytes and macrophage and FLT3, BTLA, and KIT to define DCs. Comparative biology analysis of DC subsets has supported the relevance of murine models for both developmental and functional studies and the extension of a similar analysis to the macrophage lineage could present an additional perspective for future studies on these cells. The phenotypic and transcriptional assignment of dermal CD14 + cells as monocyte-derived macrophages led us to reevaluate their ability to migrate spontaneously from skin explant cultures ex vivo which has been presumed to simulate lymphatic migration despite absent or very low expression of CCR7 even upon cytokine and LPS stimulation. We observed that although 1 in 5 HLA-DR + cells after 12 hr and 48 hr culture of skin explant were CD14 + cells, these cells were not observed within skin lymphatic lumen. The dichotomy between spontaneous migration and lymphatic migration was previously observed with murine LCs and DCs from Ccr7 À/À mice, which were capable of spontaneously migrating from skin explants but failed to form dermal cords indicative of lymphatic migration or enter skin draining lymph node (Ohl et al., 2004) . It is well documented that CD14 + cells are poor stimulators of naive T cells, a property that is expected of tissue-resident cells. However, CD14 + cells and macrophages are on par with DCs in regulating memory CD4 + T cell responses as shown here and in previous reports. Dermal CD14 + cells express high amounts of IL-1a and GGT5, a property not shared by any blood or skin DCs, monocytes, and macrophages, suggesting a role in maintaining epithelial integrity and regulation of skin inflammation including neutrophil migration (Han et al., 2002; Chen et al., 2007) . Murine tissue macrophages and epidermal Langerhans cells (LCs) were recently shown to arise from embryonic yolk sac and fetal liver precursors challenging the traditional dogma of monocytes as precursors of all tissue macrophages (van Furth and Cohn, 1968; Schulz et al., 2012; Hoeffel et al., 2012) . However, recent evidence (Yona et al., 2013; Tamoutounour et al., 2013) including this report suggests a contribution by circulating monocytes to the murine tissue macrophage pool. The functional differences between cells derived from these two origins have not been defined. The contemporary view of the mononuclear phagocyte system encompasses several precursor origins including circulating monocytes as precursors of tissue macrophages. Here, we report in humans, two populations of tissue resident cells, CD14 + monocyte-derived macrophages and 
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+ dermal cell populations found in steady state and upon contact sensitization with DNFB. P1, tissue monocytes; P2 and P3, dermal monocyte-derived DC-like cells; P4 and P5, dermal macrophages, as described in (Tamoutounour et al., 2013) . All enrichment scores were significant at p < 0.001. P4 and P5, dermal macrophages; as described in (Tamoutounour et al., 2013) . Data shown is representative of six individually analyzed mice from two independent experiments.
EXPERIMENTAL PROCEDURES Cell Isolation and Culture
Human samples were obtained in accordance with a favorable ethical opinion from Newcastle, Singapore SingHealth, and National Health Care Group Research Ethics Committees. Normal skin was obtained from mammoplasty and breast reconstruction surgery and digested whole (1 3 1 cm 2 ) as previously described (Haniffa et al., 2012) to obtain single-cell suspension. Migrating cells were collected from whole skin pieces (1 3 1 cm 2 ) cultured in RPMI with 10% FCS, and analyzed at serial time points between 0 and 72 hr. Viability was >90% by DAPI exclusion (Sigma 
Flow Cytometry
Flow cytometry was performed on a BDLSRII, BDFortessa, and FACSCanto, and data were analyzed with FlowJo (Treestar). Antibodies used are listed in Supplemental Experimental Procedures.
Microscopy
Whole-mount immunofluorescence staining was performed with a previously described protocol (Wang et al., 2014) . We fixed a 200 mm skin sheet in PBS containing 2% paraformaldehyde and 30% sucrose overnight at 4 C. Skin was incubated overnight in PBS containing 0.5% BSA and 0.3% Triton X-100 before staining with primary and secondary antibodies at 4 C overnight at each stage. Antibodies used are listed in Supplemental Experimental Procedures. After staining, tissue samples were immersed in VECTASHIELD mounting medium with DAPI (Vector Laboratories). Specimens were viewed using Axio Imager.Z2 fluorescence microscope with Axiovision software v4.8 and Axiocam MR3 camera (Carl Zeiss, Inc.) or Leica Leica TCS SP2 UV confocal microscope and LCS V 2.51 imaging software (Leica). Three-dimensional reconstruction was performed with Imaris7.6.2 soft-ware (www. bitplane.com).
T Cell Alloreaction and Cytokine Production Assays
We cultured 5,000 FACS-sorted dermal DC subsets with 100,000 CFSElabeled allogeneic naive (CD4 + CD25
T cells in U-bottomed 96-well plate. Proliferation was measured by CFSE dilution on day 6. For memory T cell stimulation, autologous blood CD4 + T cells were used to measure recall memory response to Candida albicans. We pulsed 5,000 FACSsorted dermal DC subsets with Candida albicans overnight, and cultured them with 100,000 CFSE-labeled (Invitrogen) autologous blood CD4 + T cells on the following day. Media was replenished as necessary throughout the duration of the culture. Cytokine production was measured on day 10, upon stimulation with 20 ng/ml PMA (Sigma-Aldrich; Sigma) and 500 ng/ml Ionomycin (Sigma) for 5 hr in the presence of 10 mg/ml Brefeldin A (Sigma-Aldrich) for the last 2 hr. Cells were fixed and permeabilized (eBioscience Fix/ Perm Buffer Set) to allow intracellular cytokine staining. Viaprobe staining (Becton Dickinson; BD) was performed prior to cell fixation to distinguish viable cells.
Blood Monocyte Coculture with HUVECs and Dermal Fibroblasts
HUVECs were cultured in Endothelial Cell Basal Medium 2 (Promo Cell) with the following supplements (FCS, endothelial cell growth supplement, epidermal growth factor, Insulin-like growth factor, vascular endothelial growth factor 165, ascorbic acid, heparin, hydrocortisone [Promo cell]). Dermal fibroblasts were cultured in RPMI with 20% FCS, 1000 u/ml Penicillin and Streptomycin and 2mM L-Glutamine. HUVECs or fibroblasts (30,000/well) were seeded in a 24-well plate and cultured in their respective media (500 ml) for 18 hr at 37 C, 5% CO 2 . FACS-purified blood monocyte subsets were added to HUVECs or fibroblast cell cultures (50,000 monocytes/well to a final volume 1 ml) and analyzed on days 1 and 3 after coculture.
Trucount Processing and Analysis
Absolute whole-blood leukocyte analysis was performed as described previously (Jardine et al., 2013) . Briefly, 100 ml of whole blood was transferred directly to Trucount tubes (BD). Antibodies were added directly and staining was performed at RT for 20 min, followed by red blood cell lysis by adding 900 ml of BD PharmLyse reagent for 10 min at RT. Samples were then analyzed directly by flow-cytometry. Absolute number of cells per microliters of blood was calculated according to the manufacturer's protocol.
Mouse Dermal Skin Cells Preparation S100a4-cre mice were purchased from Jackson Laboratory and crossed to R26-stop-EYFP mice in house. Animals positive for the R26-stop-EYFP-flox construct were used for the experiment. Only sex (female) and aged (6-8 weeks) matched mice were used. Mouse skin cells were isolated as described previously (Ginhoux et al., 2007) . Briefly, mouse ears were split into dorsal and ventral halves and floated in RPMI-1640 medium (Sigma) containing 1 mg/ml dispase (Invitrogen) for 60 min to allow separation of epidermal and dermal sheets. Dermal sheets were then cut into small pieces and incubated in RPMI containing 10% serum and 0.8 mg/ml collagenase type IV (Worthington-Biochem; 250 U/mg) for 2 hr. Cells were then passed through 19 G syringe and filtered through 100 uM cell strainer (BD Falcon) to obtain a homogenous cell suspension.
Quantitative Real-Time PCR Total RNA was extracted using the RNeasy Micro Kit (QIAGEN) and treated with DNase I according to manufacturers' instructions (QIAGEN 
Statistical Analyses
All statistical analyses were performed using Prism 5.0 (GraphPad Software).
All p values are two-tailed using Mann-Whitney U test.
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